Female and Male Pelvic Health Issues deserve the very best medical attention.

Count on us for the private, personal, & professional attention you need.

The Center for Pelvic Medicine

The Center for Pelvic Medicine is a national leader in treating female and male pelvic health problems.

We provide convenient access to advanced care for conditions in female and male urinary and pelvic health.

doorplaque

 

Dr. Susan Kellogg Spadt, PhD, CRNP, IF, FCST

Dr. Susan Kellogg Spadt, PhD, CRNP, IF, FCST is the Director of Female Sexual Medicine at the Center for Pelvic Medicine, located at the Bryn Mawr division of Academic Urology of PA, LLC. Member of the editorial board of The Journal of Sexual Medicine.

 

Jennifer Yonaitis Fariello, MSN, RNC, CRNP

Jennifer Yonaitis Fariello, MSN, RNC, CRNP  is Nurse Practitioner for female and male Pelvic and Sexual Medicine and the Center for Pelvic Medicine located in the Bryn Mawr division of Academic Urology of PA, LLC.

 

Elizabeth Kusturiss, MSN, CRNP

Elizabeth Kusturiss, MSN, CRNPis a Nurse Practitioner in Female Sexual Medicine at the Center for Pelvic Medicine located in the Bryn Mawr division of Academic Urology of PA, LLC.

 

The Center for Pelvic Medicine accepts all major insurance plans.

News

Follow @Doctor_Kellogg

June 7, 2015: Dr. Kellogg Approves Female Libido Pill Flibanserin CBS News

Dr. Kellogg CBS News Approves Flibanserin  first FDA Libido drug Approved for Women.

 VIDEO

Get “the little pink pill” Flibanserin used For Women with low desire low sex drive from Center for Pelvic Medicine in Rosemont PA

The pill is to boost women’s sexual desire. The “little pink pill” is one step closer to going on the market. After saying no twice, an FDA panel finally recommended the first medication for female sexual dysfunction. Unlike  drugs for men, like Viagra, which improve blood flow, Flibanserin is an anti-depressant that works on the pleasure center of the brain.

The pill, however, comes with side effects, which include insomnia, nausea and dizziness. As always, women will need to decide whether the risks versus the benefits compared to other treatment alternatives are worth it for them.

The panel of Food and Drug Administration advisers voted 18-6 in favor of Sprout Pharmaceutical’s daily pill, flibanserin, on the condition that the company develops a plan to manage its risks.

 

August 6, 2014: Vulvar Pain Relief in Menopausal Women with Neogyn

New Study Proves Neogyn Significantly Helps Menopausal Women Alleviate Vulvar Pain, Improve Sex Lives

Neogyn is available from Dr. Susan Kellogg Spadt, located at the Center For Pelvic Medicine.

A new study spearheaded by the Southern California Center for Health & Survivorship Medicine and the Academic Urology Center for Pelvic Medicine concludes that the vulvar-soothing cream Neogyn meaningfully alleviates these symptoms in otherwise-healthy post-menopausal women.

Dr. Susan Kellogg Spadt, PhD, sexual health expert and Director of Female Sexual Medicine at the Academic Urology Center for Pelvic Medicine outside of Philadelphia, and another of the study’s authors, points out that any woman might develop vaginal pain and discomfort, but the following categories of women are especially vulnerable: menopausal and post-menopausal women, birth control users, cancer survivors and women with certain chronic medical conditions.